BRCA2mutation carriers, reproductive factors and breast cancer risk

被引:0
|
作者
Laufey Tryggvadottir
Elinborg J Olafsdottir
Sigfridur Gudlaugsdottir
Steinunn Thorlacius
Jon G Jonasson
Hrafn Tulinius
Jorunn E Eyfjord
机构
[1] Icelandic Cancer Registry,Faculty of Medicine
[2] Molecular and Cell Biology Laboratory of the Icelandic Cancer Society,undefined
[3] University of Iceland,undefined
[4] Iceland Genomics Corporation,undefined
来源
关键词
breast cancer; cohort study; risk factors;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers
    Milne, Roger L.
    Osorio, Ana
    Ramon y Cajal, Teresa
    Baiget, Montserrat
    Lasa, Adriana
    Diaz-Rubio, Eduardo
    de la Hoya, Miguel
    Caldes, Trinidad
    Teule, Alex
    Lazaro, Conxi
    Blanco, Ignacio
    Balmana, Judith
    Sanchez-Olle, Gessami
    Vega, Ana
    Blanco, Ana
    Chirivella, Isabel
    Esteban Cardenosa, Eva
    Duran, Mercedes
    Velasco, Eladio
    Martinez de Duenas, Eduardo
    Tejada, Maria-Isabel
    Miramar, Maria-Dolores
    Calvo, Maria-Teresa
    Guillen-Ponce, Carmen
    Salazar, Raquel
    San Roman, Carlos
    Urioste, Miguel
    Benitez, Javier
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 119 (01) : 221 - 232
  • [42] Age at menarche and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
    Kotsopoulos, J
    Lubinski, J
    Lynch, HT
    Neuhausen, SL
    Ghadirian, P
    Isaacs, C
    Weber, B
    Kim-Sing, C
    Foulkes, WD
    Gershoni-Baruch, R
    Ainsworth, P
    Friedman, E
    Daly, M
    Garber, JE
    Karlan, B
    Olopade, OI
    Tung, N
    Saal, HM
    Eisen, A
    Osborne, M
    Olsson, H
    Gilchrist, D
    Sun, P
    Narod, SA
    CANCER CAUSES & CONTROL, 2005, 16 (06) : 667 - 674
  • [43] Parity and breast cancer risk among BRCA1 and BRCA2 mutation carriers
    Antoniou, Antonis C.
    Shenton, Andrew
    Maher, Eamonn R.
    Watson, Emma
    Woodward, Emma
    Lalloo, Fiona
    Easton, Douglas F.
    Evans, D. Gareth
    BREAST CANCER RESEARCH, 2006, 8 (06)
  • [44] Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers
    Roger L. Milne
    Ana Osorio
    Teresa Ramón y Cajal
    Montserrat Baiget
    Adriana Lasa
    Eduardo Diaz-Rubio
    Miguel de la Hoya
    Trinidad Caldés
    Alex Teulé
    Conxi Lázaro
    Ignacio Blanco
    Judith Balmaña
    Gessamí Sánchez-Ollé
    Ana Vega
    Ana Blanco
    Isabel Chirivella
    Eva Esteban Cardeñosa
    Mercedes Durán
    Eladio Velasco
    Eduardo Martínez de Dueñas
    María-Isabel Tejada
    María-Dolores Miramar
    María-Teresa Calvo
    Carmen Guillén-Ponce
    Raquel Salazar
    Carlos San Román
    Miguel Urioste
    Javier Benítez
    Breast Cancer Research and Treatment, 2010, 119 : 221 - 232
  • [45] Body weight and risk of breast cancer in BRCA1/2 mutation carriers
    Peggy Manders
    Anouk Pijpe
    Maartje J. Hooning
    Irma Kluijt
    Hans F. A. Vasen
    Nicoline Hoogerbrugge
    Christi J. van Asperen
    Hanne Meijers-Heijboer
    Margreet G. E. M. Ausems
    Theo A. van Os
    Encarna B. Gomez-Garcia
    Richard M. Brohet
    Flora E. van Leeuwen
    Matti A. Rookus
    Breast Cancer Research and Treatment, 2011, 126 : 193 - 202
  • [46] Risk of contralateral breast cancer amongst BRCA1/2 mutation carriers
    Basu, Narendra Nath
    Evans, D. Gareth
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S1066 - S1069
  • [47] Body weight and risk of breast cancer in BRCA1/2 mutation carriers
    Manders, Peggy
    Pijpe, Anouk
    Hooning, Maartje J.
    Kluijt, Irma
    Vasen, Hans F. A.
    Hoogerbrugge, Nicoline
    van Asperen, Christi J.
    Meijers-Heijboer, Hanne
    Ausems, Margreet G. E. M.
    van Os, Theo A.
    Gomez-Garcia, Encarna B.
    Brohet, Richard M.
    van Leeuwen, Flora E.
    Rookus, Matti A.
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 126 (01) : 193 - 202
  • [48] Cancer risk-modifying factors in BRCA1 or BRCA2 mutation carriers
    Rebbeck, TR
    FAMILIAL CANCER AND PREVENTION: MOLECULAR EPIDEMIOLOGY - A NEW STRATEGY TOWARD CANCER CONTROL, 1999, : 413 - 418
  • [49] Telomere Length Is Predictive of Breast Cancer Risk in BRCA2 Mutation Carriers
    Thorvaldsdottir, Birna
    Aradottir, Margret
    Stefansson, Olafur A.
    Bodvarsdottir, Sigridur K.
    Eyfjord, Jorunn E.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2017, 26 (08) : 1248 - 1254
  • [50] Physical activity and the risk of breast cancer in BRCA1/2 mutation carriers
    Anouk Pijpe
    Peggy Manders
    Richard M. Brohet
    J. Margriet Collée
    Senno Verhoef
    Hans F. A. Vasen
    Nicoline Hoogerbrugge
    Christi J. van Asperen
    Charlotte Dommering
    Margreet G. E. M. Ausems
    Cora M. Aalfs
    Encarna B. Gomez-Garcia
    Laura J. van‘t Veer
    Flora E. van Leeuwen
    Matti A. Rookus
    Breast Cancer Research and Treatment, 2010, 120 : 235 - 244